Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
79.64
+1.16 (1.48%)
At close: Dec 5, 2025, 4:00 PM EST
79.89
+0.25 (0.31%)
After-hours: Dec 5, 2025, 7:54 PM EST
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $15.40 billion as of December 5, 2025. Its market cap has increased by 62.07% in one year.
Market Cap
15.40B
Enterprise Value
13.88B
1-Year Change
62.07%
Ranking
Category
Stock Price
$79.64
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $15.40B, an increase of 836.22%. That is a compound annual growth rate of 46.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 15.40B | 90.47% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |